RÉSUMÉ
Despite more than 50 years of vaccination, pertussis is still an endemic disease, with regular epidemic outbreaks. With the exception of Poland, European countries have replaced whole-cell vaccines (WCVs) by acellular vaccines (ACVs) in the 1990s. Worldwide, antigenic divergence in vaccine antigens has been found between vaccine strains and circulating strains. In this work, 466 Bordetella pertussis isolates collected in the period 1998-2012 from 13 European countries were characterised by multi-locus antigen sequence typing (MAST) of the pertussis toxin promoter (ptxP) and of the genes coding for proteins used in the ACVs: pertussis toxin (Ptx), pertactin (Prn), type 2 fimbriae (Fim2) and type 3 fimbriae (Fim3). Isolates were further characterised by fimbrial serotyping, multi-locus variable-number tandem repeat analysis (MLVA) and pulsed-field gel electrophoresis (PFGE). The results showed a very similar B. pertussis population for 12 countries using ACVs, while Poland, which uses a WCV, was quite distinct, suggesting that ACVs and WCVs select for different B. pertussis populations. This study forms a baseline for future studies on the effect of vaccination programmes on B. pertussis populations.
Sujet(s)
Bordetella pertussis/classification , Bordetella pertussis/isolement et purification , Variation génétique , Coqueluche/épidémiologie , Coqueluche/microbiologie , Antigènes bactériens/génétique , Bordetella pertussis/génétique , Électrophorèse en champ pulsé , Europe/épidémiologie , Humains , Répétitions minisatellites , Épidémiologie moléculaire , Typage par séquençage multilocus , Toxine pertussique/génétique , Régions promotrices (génétique) , SérotypieRÉSUMÉ
Pertussis or whooping cough has persisted and resurged in the face of vaccination and has become one of the most prevalent vaccine-preventable diseases in Western countries. The high circulation rate of Bordetella pertussis poses a threat to infants that have not been (completely) vaccinated and for whom pertussis is a severe, life-threatening, disease. The increase in pertussis is mainly found in age groups in which immunity has waned and this has resulted in the perception that waning immunity is the main or exclusive cause for the resurgence of pertussis. However, significant changes in B. pertussis populations have been observed after the introduction of vaccinations, suggesting a role for pathogen adaptation in the persistence and resurgence of pertussis. These changes include antigenic divergence with vaccine strains and increased production of pertussis toxin. Antigenic divergence will affect both memory recall and the efficacy of antibodies, while higher levels of pertussis toxin may increase suppression of the innate and acquired immune system. We propose these adaptations of B. pertussis have decreased the period in which pertussis vaccines are effective and thus enhanced the waning of immunity. We plead for a more integrated approach to the pertussis problem which includes the characteristics of the vaccines, the B. pertussis populations and the interaction between the two.
Sujet(s)
Bordetella pertussis , Maladies transmissibles émergentes , Vaccin anticoquelucheux/immunologie , Coqueluche , Séquence d'acides aminés , Bordetella pertussis/immunologie , Bordetella pertussis/pathogénicité , Épidémies , Humains , Données de séquences moléculaires , Mutation , Toxine pertussique/composition chimique , Toxine pertussique/immunologie , Alignement de séquencesRÉSUMÉ
Bordetella pertussis strains with the pertussis toxin promoter allele ptxP3 have expanded and replaced resident ptxP1 strains in several European countries. We developed an allele-specific real-time PCR method to identify strains with the allele ptxP3, and investigated the emergence of ptxP3 strains by genotyping Finnish clinical isolates (n = 524) from 1953 to 2010. The first ptxP3 strain was detected in 1994, and has become predominant since 2003. Our results demonstrate that the allele-specific real-time PCR is a suitable method for rapid detection of ptxP3 strains, and show the emergence and establishment of ptxP3 strains in Finland.
Sujet(s)
Allèles , Bordetella pertussis/isolement et purification , Typage moléculaire/méthodes , Toxine pertussique/génétique , Réaction de polymérisation en chaine en temps réel/méthodes , Bordetella pertussis/classification , Bordetella pertussis/génétique , ADN bactérien/génétique , Finlande/épidémiologie , Gènes bactériens , Humains , Incidence , Prévalence , Régions promotrices (génétique) , Coqueluche/épidémiologie , Coqueluche/microbiologieRÉSUMÉ
BACKGROUND: We conducted a population-based, nation-wide, prospective study to identify who introduced pertussis into the household of infants aged 6 months admitted to the hospital for pertussis in the Netherlands. METHODS: During the period 2006-2008, a total of 560 household contacts of 164 hospitalized infants were tested by polymerase chain reaction, culture, and serological examination to establish Bordetella pertussis infection. Clinical symptoms and vaccination history were obtained by a questionnaire submitted during sample collection and 4-6 weeks afterwards. RESULTS: Overall, 299 household contacts (53%) had laboratory-confired pertussis; 159 (53%) had symptoms compatible with typical pertussis infection, and 42 (14%) had no symptoms. Among children vaccinated with a whole-cell vaccine, 17 (46%) of 37 had typical pertussis 1-3 years after completion of the primary series, compared with 9 (29%) of 31 children who had been completely vaccinated with an acellular vaccine. For 96 households (60%), the most likely source of infection of the infant was established, being a sibling (41%), mother (38%), or father (17%). CONCLUSIONS: If immunity to pertussis in parents is maintained or boosted, 35%-55% of infant cases could be prevented. Furthermore, we found that, 1-3 years after vaccination with whole-cell or acellular vaccine, a significant percentage of children are again susceptible for typical pertussis. In the long term, pertussis vaccines and vaccination strategies should be improved to provide longer protection and prevent transmission.
Sujet(s)
Bordetella pertussis/isolement et purification , Santé de la famille , Coqueluche/prévention et contrôle , Coqueluche/transmission , Anticorps antibactériens/sang , Bordetella pertussis/génétique , Bordetella pertussis/immunologie , ADN bactérien/génétique , Caractéristiques familiales , Femelle , Humains , Nourrisson , Nouveau-né , Mâle , Pays-Bas/épidémiologie , Réaction de polymérisation en chaîne , Études prospectives , Enquêtes et questionnaires , Vaccination/statistiques et données numériques , Coqueluche/épidémiologie , Coqueluche/anatomopathologieRÉSUMÉ
Three Bordetella pertussis typing methods, pulsed-field gel electrophoresis (PFGE), multi-locus sequence typing (MLST), and multi-locus variable number tandem repeat analysis (MLVA) were compared using a collection of Swedish strains. Of the three typing methods used, PFGE was found to be the most discriminatory. MLVA and MLST were less discriminatory, but may be valuable for strain discrimination when culture is not possible as they are based on PCR. The combination of MLVA/MLST was found to be equally discriminatory as PFGE and should therefore also be considered. The relationship between predominant lineages in Sweden and The Netherlands, characterized by the PFGE type BpSR11 and the allele for the pertussis toxin promoter ptxP3, respectively, was investigated. Linkage was found between the PFGE type BpSR11 and ptxP3 in that all BpSR11 strains carried ptxP3. On the other hand ptxP3 was found in several other PFGE-types. The presence of the ptxP3 allele in different genetic backgrounds may indicate horizontal gene transfer within B. pertussis or homoplasy. Alternatively, this observation may be due to convergence of PFGE types.
Sujet(s)
Techniques de typage bactérien/méthodes , Bordetella pertussis/classification , Bordetella pertussis/génétique , Profilage d'ADN/méthodes , Coqueluche/épidémiologie , Coqueluche/microbiologie , Allèles , Bordetella pertussis/isolement et purification , Analyse de regroupements , ADN bactérien/composition chimique , ADN bactérien/génétique , Électrophorèse en champ pulsé/méthodes , Humains , Répétitions minisatellites , Épidémiologie moléculaire/méthodes , Données de séquences moléculaires , Réaction de polymérisation en chaîne/méthodes , Sensibilité et spécificité , Analyse de séquence d'ADN/méthodes , Suède/épidémiologieRÉSUMÉ
To gain insight into pertussis disease dynamics, we studied age-specific long-term periodicity and seasonality of pertussis in The Netherlands. Hierarchical time-series models were used to analyse the monthly reported pertussis incidence in January 1996-June 2006 by age group. The incidence of pertussis showed a slightly increasing long-term trend with highest incidence rates seen in 1996, 1999, 2001 and 2004. For all age groups the annual peak incidence was found in August, except for the 13-18 years age group where the peak occurred in November. Monthly trends in adults showed high correlation with trends in age groups 0-4 years (0.94) and 5-12 years (0.92). We found no evidence for a relationship between annual rises in pertussis and the opening of schools. Concurrent annual fluctuations of pertussis incidence in adults and infants suggest frequent transmission within and between these age groups. Studying trends offers insight into transmission dynamics and may facilitate decisions on future vaccination strategies.
Sujet(s)
Saisons , Coqueluche/épidémiologie , Coqueluche/transmission , Adolescent , Adulte , Facteurs âges , Sujet âgé , Sujet âgé de 80 ans ou plus , Enfant , Enfant d'âge préscolaire , Femelle , Humains , Incidence , Nourrisson , Nouveau-né , Mâle , Adulte d'âge moyen , Pays-Bas/épidémiologie , Jeune adulteRÉSUMÉ
The virulence factor pertactin is expressed by the closely related pathogens Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica. Pertactin is an autotransporter involved in adherence of Bordetella species to the lung epithelium of mammalian hosts, and it is an important component of most current acellular pertussis vaccines. These three species produce immunologically distinct pertactin molecules, resulting in a lack of cross-protection against B. parapertussis and probably also against B. bronchiseptica. Variation in pertactin is not only inter-specific, but also occurs between isolates from the same species. Knowledge about codons that are under positive selection could facilitate the development of more broadly protective vaccines. Using different nucleotide substitution models, pertactin genes from B. bronchiseptica, B. parapertussis and B. pertussis were compared, and positively selected codons were identified using an empirical Bayesian approach. This approach yielded 15 codons predicted to be under diversifying selection pressure. These results were interpreted in an immunological context and may help in improving future pertussis vaccines.
Sujet(s)
Protéines de la membrane externe bactérienne/génétique , Bordetella/génétique , Évolution moléculaire , Facteurs de virulence des Bordetella/génétique , Séquence nucléotidique , Bordetella bronchiseptica/génétique , Bordetella parapertussis/génétique , Bordetella pertussis/génétique , Codon/génétique , Modèles moléculaires , Sélection génétiqueRÉSUMÉ
The recently discovered pathogen Bordetella holmesii has been isolated from the airways and blood of diseased humans. Genetic events contributing to the emergence of B. holmesii are not understood, and its phylogenetic position among the bordetellae remains unclear. To address these questions, B. holmesii strains were analyzed by comparative genomic hybridization (CGH) to a Bordetella pertussis microarray and by multilocus sequence typing. Both methods indicated substantial sequence divergence between B. pertussis and B. holmesii. However, CGH identified a putative pathogenicity island of 66 kb that is highly conserved between these species and contains several IS481 elements that may have been laterally transferred from B. pertussis to B. holmesii. This island contains, among other genes, a functional, iron-regulated locus encoding the biosynthesis, export, and uptake of the siderophore alcaligin. The acquisition of this genomic island by B. holmesii may have significantly contributed to its emergence as a human pathogen. Horizontal gene transfer between B. pertussis and B. holmesii may also explain the unusually high sequence identity of their 16S rRNA genes.
Sujet(s)
Bordetella pertussis/classification , Bordetella pertussis/génétique , Bordetella/classification , Bordetella/génétique , Ilots génomiques/génétique , Protéines bactériennes/génétique , Protéines bactériennes/métabolisme , Bordetella/isolement et purification , Bordetella pertussis/isolement et purification , Évolution moléculaire , Génome bactérien , Humains , Acides hydroxamiques/métabolisme , Données de séquences moléculaires , Hybridation d'acides nucléiques , Séquençage par oligonucléotides en batterie , Phylogenèse , Analyse de séquence d'ADNRÉSUMÉ
The susceptibility to and the severity of Bordetella pertussis infections in infants and children varies widely, suggesting that genetic differences between individuals influence the course of infection. We have previously identified three novel loci that influence the severity of whooping cough by using recombinant congenic strains of mice: Bordetella pertussis susceptibility loci 1, 2, and 3 (Bps1, -2, and -3). Because these loci could not account for all genetic differences between mice, we extended our search for additional susceptibility loci. We therefore screened 11 inbred strains of mice for susceptibility to a pertussis infection after intranasal infection. Susceptibility was defined by the number of bacteria in the lungs, being indicative of the effect between the clearance and replication of bacteria. The most resistant (A/J) and the most susceptible (C3H/HeJ) strains were selected for further genetic and phenotypic characterization. The link between bacterial clearance and chromosomal location was investigated with 300 F2 mice, generated by crossing A/J and C3H/HeJ mice. We found a link between the delayed clearance of bacteria from the lung and a large part of chromosome 4 in F2 mice with a maximum log of the odds score of 33.6 at 65.4 Mb, which is the location of Tlr4. C3H/HeJ mice carry a functional mutation in the intracellular domain of Tlr4. This locus accounted for all detectable genetic differences between these strains. Compared to A/J mice, C3H/HeJ mice showed a delayed clearance of bacteria from the lung, a higher relative lung weight, and increased body weight loss. Splenocytes from infected C3H/HeJ mice produced almost no interleukin-1beta (IL-1beta) and tumor necrosis factor alpha (TNF-alpha) upon ex vivo restimulation with B. pertussis compared to A/J mice and also showed a delayed gamma interferon (IFN-gamma) production. TNF-alpha expression in the lungs 3 days after infection was increased fivefold compared to uninfected controls in A/J mice and was not affected in C3H/HeJ mice. In conclusion, Tlr4 is a major host factor explaining the differences in the course of infection between these inbred strains of mice. Functional Tlr4 is essential for an efficient IL-1-beta, TNF-alpha, and IFN-gamma response; efficient clearance of bacteria from the lung; and reduced lung pathology.
Sujet(s)
Prédisposition génétique à une maladie , Récepteur de type Toll-4/physiologie , Coqueluche/génétique , Animaux , Cytokines/biosynthèse , Liaison génétique , Poumon/anatomopathologie , Souris , Souris de lignée BALB C , Souris de lignée C3H , Facteur de nécrose tumorale alpha/génétique , Coqueluche/anatomopathologieRÉSUMÉ
In Argentina, as in other countries, the number of pertussis cases has been increasing, even in highly vaccinated zones. Many reports suggest that the decline of vaccine efficacy due to antigenic shifts in the circulating Bordetella pertussis might be among the factors that contribute to pertussis re-emergence in different parts of the world. To evaluate the incidence of this factor in Argentina, we decided to characterize the circulating bacteria of an important demographic area of this country in comparison with the strain used for vaccine production. From 1997 to 2003 we collected nasopharyngeal samples from pediatric patients with signs of Bordetella infection hospitalized in the metropolitan area of Buenos Aires and La Plata, Argentina. From these samples we identified 28 B. pertussis, which were characterized by biochemical techniques, PCR, DNA fingerprint, prn and ptx genes sequencing, and lipopolysaccharides (LPS) pattern. BOX-PCR from B. pertussis isolates yielded one cluster containing 13 isolates and some smaller ones, being all fingerprints different from the vaccine strain. Differences between Argentinean circulating bacteria and the vaccine strain were also observed for the Prn and Ptx variants as well as for the LPS pattern. Moreover, this last pattern seemed to change over the years. In addition, we identified two B. bronchiseptica. The presence of this Bordetella species together with the observed differences between circulating B. pertussis and the strain used in vaccine production should be considered for the development of an improved vaccine.
Sujet(s)
Bactériémie/microbiologie , Bordetella pertussis/génétique , Vaccin anticoquelucheux , Adulte , Argentine , Protéines de la membrane externe bactérienne/génétique , Bordetella pertussis/immunologie , Bordetella pertussis/pathogénicité , Profilage d'ADN , Humains , Lipopolysaccharides/analyse , Adulte d'âge moyen , Partie nasale du pharynx/microbiologie , Toxine pertussique/génétique , Réaction de polymérisation en chaîne , Virulence , Facteurs de virulence des Bordetella/génétiqueRÉSUMÉ
Despite the widespread use of pertussis vaccines during the last decades, pertussis has remained an endemic disease with frequent epidemic outbreaks. Currently two types of vaccines are used: whole-cell vaccines (WCVs) and recently developed acellular vaccines (ACVs). The long-term aim of our studies is to assess the effect of different vaccination policies on the population structure of Bordetella pertussis and ultimately on the disease burden in Europe. In the present study, a total of 102 B. pertussis isolates from the period 1998 to 2001 from five European countries (Finland, Sweden, Germany, The Netherlands, and France) were characterized. The isolates were analyzed by typing based on variable number of tandem repeats (VNTR); by sequencing of polymorphic genes encoding the surface proteins pertussis toxin S1 and S3 subunits (ptxA and ptxC), pertactin (prn), and tracheal colonization factor (tcfA); and by fimbrial serotyping. The results reveal a relationship between geographic location and VNTR types, the frequency of the ptxC alleles, and serotypes. We have not observed a relationship between the strain characteristics we studied and vaccination programs. Our results provide a baseline which can be used to reveal changes in the B. pertussis population in Europe in the coming years.
Sujet(s)
Bordetella pertussis/isolement et purification , Politique de santé , Programmes de vaccination , Vaccin anticoquelucheux/administration et posologie , Coqueluche/épidémiologie , Adolescent , Adulte , Protéines bactériennes/génétique , Bordetella pertussis/classification , Bordetella pertussis/génétique , Enfant , Enfant d'âge préscolaire , Europe , Protéines de fimbriae , Humains , Nourrisson , Nouveau-né , Répétitions minisatellites/génétique , Polymorphisme génétique , Sérotypie , Vaccination , Facteurs de virulence/génétique , Coqueluche/microbiologie , Coqueluche/prévention et contrôleRÉSUMÉ
OBJECTIVE: To determine whether booster vaccination of 4-year-old children with an acellular pertussis vaccine, which has been included in the national vaccination programme since October 2001, has decreased the incidence of pertussis. DESIGN: Descriptive. METHODS: Surveillance data were studied: mandatory notifications to the Health Inspectorate and reports of hospital admissions from the National Medical Register. RESULTS: During the past 7 years, there has been an increase in the incidence of pertussis every 2-3 years (1996, 1999, 2001). Moreover, the annual incidence in 1996-2003 was higher than in 1989-1995. As in previous years, the yearly peak incidence for hospital admissions due to pertussis was observed among nurslings, especially those younger than 3 months of age. In 2002 compared to 2000, the incidence among 3-4-year-olds on the basis of notifications and hospitalisations was 45% and 62% lower, respectively, very likely due to the booster vaccination for 4-year-olds introduced in 2001. The greatest decrease in the incidence was also observed among the 4-year-olds in 2003. CONCLUSION: Pertussis is still endemic in The Netherlands with a higher incidence than before the epidemic of 1996-1997. Severe disease often occurs, especially among unvaccinated children < 1 year of age. From January 2005 onwards, the vaccinations in the first year of life have been given with an acellular pertussis vaccine. However, since such infants are too young to be protected by vaccination alone, more information is needed on the most important sources of infection of nurslings in The Netherlands.
Sujet(s)
Vaccin anticoquelucheux/administration et posologie , Coqueluche/prévention et contrôle , Adolescent , Adulte , Facteurs âges , Sujet âgé , Sujet âgé de 80 ans ou plus , Enfant , Enfant d'âge préscolaire , Femelle , Humains , Rappel de vaccin , Incidence , Nourrisson , Nouveau-né , Mâle , Adulte d'âge moyen , Pays-Bas/épidémiologie , Vaccin anticoquelucheux/pharmacologie , Coqueluche/épidémiologieRÉSUMÉ
Susceptibility to and severity of Bordetella pertussis infection in infants and children vary widely. The spectrum of clinical symptoms ranges from subclinical infection to mild disease, severe whooping cough, and death. The aims of this study were to examine genetic susceptibilities of mice to B. pertussis and to identify genetic loci in the mouse genome that are involved in susceptibility to B. pertussis infection. For this purpose we screened two sets of recombinant congenic strains (RCS) of mice, HcB and CcS, for differences in the numbers of bacteria in the lung 7 days after inoculation. For both CcS and in HcB mice, a wide range in numbers of bacteria in the lung was found, suggesting that the course of infection is under multigenic control. From both RCS sets of mice, we selected one strain to identify possible susceptibility loci in F(2) hybrid mice. The degree of lung colonization 7 days postinoculation in these F(2) mice was evaluated in relation to genetic markers by linkage analysis. We found three novel loci that are involved in the control of B. pertussis infection. One locus, designated B. pertussis susceptibility locus 1 (Bps-1), was identified on chromosome 12. The presence of the C57BL/10 genome on this locus instead of the C3H genome significantly decreased the number of B. pertussis bacteria in the lung. Bps-1 has a dominant-positive effect on the clearance of B. pertussis from the lung. The function of most genes in this region is unknown. Two other loci, Bps-2 and Bps-3, showed genetic interaction and are located on chromosomes 5 and 11. We aim to identify the gene(s) in these regions which modify susceptibility to B. pertussis.
Sujet(s)
Bordetella pertussis/immunologie , Prédisposition génétique à une maladie , Coqueluche/génétique , Coqueluche/immunologie , Animaux , Cartographie chromosomique , Modèles animaux de maladie humaine , Femelle , Liaison génétique , Marqueurs génétiques , Lod score , Poumon/immunologie , Poumon/microbiologie , Souris , Souris congéniquesRÉSUMÉ
Australia experienced a resurgence of pertussis in the 1990s despite improved vaccine coverage. Although much of the increase was attributable to increased detection of cases in older persons with waning immunity by serology, vaccine changes or alterations in circulating Bordetella pertussis strains may also have contributed. We determined the frequency of variants of B. pertussis pertactin (prn), and pertussis toxin subunit 1 (ptxS1) genes, restriction fragment length polymorphism (RFLP) types and fimbrial serotypes prevalent in Australia prior to, and during the 1990s. Ampoules of the whole-cell vaccine in use prior to 1999 and 84 B. pertussis isolates stored between 1967 and 1998 by laboratories around Australia were analysed. One pertactin allele, Prn3, not detected before 1985, was found in 24 out of 57 (42%) isolates between 1989 and 1998 (P<0.0001). PtxS1A was found in all isolates. IS1002 type 29, found in 17 out of 31 (55%) isolates tested, was the predominant RFLP type. The only difference in fimbrial serotype distribution between the time-periods was an increase in serotype 3 (P=0.054). The whole-cell vaccine contained only the alleles prn1 and ptxS1A. Antigenic shift in B. pertussis may have contributed to the re-emergence of pertussis in Australia. Monitoring these trends will be important as acellular vaccines are introduced and changes are made to pertussis vaccine schedules.
Sujet(s)
Bactériémie/microbiologie , Bordetella pertussis/classification , Protéines de la membrane externe bactérienne/classification , Bordetella pertussis/génétique , Bordetella pertussis/immunologie , Éléments transposables d'ADN , Humains , Toxine pertussique/classification , Sérotypie , Facteurs de virulence des Bordetella/classificationRÉSUMÉ
In several countries pertussis is re-emerging, despite a high vaccination coverage. It is suggested that antigenic divergence between Bordetella pertussis vaccine strains and circulating strains, in particular with respect to pertactin, has contributed to pertussis re-emergence. Polymorphism in pertactin is essentially limited to region 1, which is composed of repeats and is located adjacent to an Arg-Gly-Asp motif implicated in adherence. Evidence is provided for the immunological relevance of polymorphism in region 1. Region 1 was found to contain a B-cell epitope recognized in both humans and mice. Furthermore, variation in region 1 affected antibody binding and, in a mouse respiratory infection model, the efficacy of a whole-cell vaccine. Moreover, passive and active immunization indicated that region 1 confers protective immunity. An mAb directed against a linear conserved epitope conferred cross-immunity against isolates with distinct pertactin variants. The results indicate an important role of region 1 of pertactin in immunity.
Sujet(s)
Protéines de la membrane externe bactérienne/immunologie , Bordetella pertussis/immunologie , Facteurs de virulence des Bordetella , Séquence d'acides aminés , Animaux , Anticorps antibactériens/biosynthèse , Anticorps antibactériens/immunologie , Anticorps monoclonaux/immunologie , Protéines de la membrane externe bactérienne/génétique , Vaccins antibactériens/immunologie , Séquence nucléotidique , Bordetella pertussis/génétique , Bordetella pertussis/pathogénicité , Réactions croisées , ADN bactérien , Modèles animaux de maladie humaine , Cartographie épitopique , Déterminants antigéniques des lymphocytes B/immunologie , Humains , Souris , Données de séquences moléculaires , Polymorphisme génétique , Structure tertiaire des protéines , Coqueluche/immunologieRÉSUMÉ
In the Netherlands, as in many other western countries, pertussis vaccines have been used extensively for more than 40 years. Therefore, it is conceivable that vaccine-induced immunity has affected the evolution of Bordetella pertussis. Consistent with this notion, pertussis has reemerged in the Netherlands, despite high vaccination coverage. Further, a notable change in the population structure of B. pertussis was observed in the Netherlands subsequent to the introduction of vaccination in the 1950s. Finally, we observed antigenic divergence between clinical isolates and vaccine strains, in particular with respect to the surface-associated proteins pertactin and pertussis toxin. Adaptation may have allowed B. pertussis to remain endemic despite widespread vaccination and may have contributed to the reemergence of pertussis in the Netherlands.
Sujet(s)
Adaptation physiologique , Bordetella pertussis/physiologie , Maladies transmissibles émergentes/épidémiologie , Vaccin anticoquelucheux/administration et posologie , Vaccination , Coqueluche/épidémiologie , Séquence d'acides aminés , Bordetella pertussis/génétique , Bordetella pertussis/immunologie , Maladies transmissibles émergentes/microbiologie , Maladies transmissibles émergentes/prévention et contrôle , Humains , Données de séquences moléculaires , Coqueluche/microbiologie , Coqueluche/prévention et contrôleRÉSUMÉ
Infection with Bordetella pertussis, the causative agent of pertussis (whooping cough) in humans, is followed by the production of antibodies of several isotypes, including immunoglobulin A (IgA). Little is known, however, about the role of IgA in immunity against pertussis. Therefore, we studied targeting of B. pertussis to the myeloid receptor for IgA, FcalphaRI (CD89), using either IgA purified from immune sera of pertussis patients or bispecific antibodies directed against B. pertussis and FcalphaRI (CD89 BsAb). Both IgA and CD89 BsAb facilitated FcalphaRI-mediated binding, phagocytosis, and bacterial killing by human polymorphonuclear leukocytes (PMNL) and PMNL originating from human FcalphaRI-transgenic mice. Importantly, FcalphaRI targeting resulted in enhanced bacterial clearance in lungs of transgenic mice. These data support the capacity of IgA to induce anti-B. pertussis effector functions via the myeloid IgA receptor, FcalphaRI. Increasing the amount of IgA antibodies induced by pertussis vaccines may result in higher vaccine efficacy.
Sujet(s)
Anticorps antibactériens/immunologie , Antigènes CD/immunologie , Bordetella pertussis/immunologie , Immunoglobuline A/immunologie , Récepteur Fc/immunologie , Coqueluche/prévention et contrôle , Animaux , Antigènes CD/génétique , Femelle , Humains , Mâle , Souris , Souris de lignée C57BL , Souris transgéniques , Granulocytes neutrophiles/immunologie , Granulocytes neutrophiles/microbiologie , Phagocytose/immunologie , Récepteur Fc/génétiqueRÉSUMÉ
In the absence of opsonizing antibodies, Bordetella pertussis, the causative agent of pertussis, readily binds to phagocytes via complement receptor 3 (CR3). After opsonization with antibodies, binding is mediated by IgG receptors (FcgammaR). The effect of targeting B. pertussis to either FcgammaR or CR3 was studied. The fate of unopsonized B. pertussis, IgG-opsonized B. pertussis, and B. pertussis opsonized with bispecific antibodies (BsAbs) directed to CR3 or FcgammaRII/-III was compared. IgG antibodies mediated binding and phagocytosis of B. pertussis via FcgammaR by polymorphonuclear leukocytes (PMNL) in vitro. Opsonization of B. pertussis with BsAbs directed against either CR3 or FcgammaRII/-III facilitated PMNL phagocytosis; however, in vivo studies with BsAb revealed that FcgammaR-mediated uptake facilitates B. pertussis clearance, in contrast to uptake via CR3. Targeting of B. pertussis to FcgammaRII/-III in mice deficient in FcgammaRII or FcgammaRIII indicated that the protective effect is attributable to FcgammaRIII. Competition between uptake via CR3 or FcgammaR may determine the outcome of natural infection.
Sujet(s)
Anticorps antibactériens/immunologie , Bordetella pertussis/immunologie , Antigène macrophage 1/immunologie , Phagocytose , Récepteurs du fragment Fc des IgG/immunologie , Animaux , Anticorps bispécifiques/immunologie , Cellules cultivées , Femelle , Immunoglobuline G/immunologie , Antigène macrophage 1/génétique , Mâle , Souris , Souris de lignée C57BL , Souris knockout , Granulocytes neutrophiles/immunologie , Opsonines/immunologie , Récepteurs du fragment Fc des IgG/génétique , Coqueluche/immunologieRÉSUMÉ
We analyzed pertussis reporting, death, hospitalization, and serodiagnostic data from 1976 to 1998 to help explain the cause of the 1996 pertussis outbreak in the Netherlands. The unexpected outbreak was detected by an increase in pertussis reporting and by other surveillance methods. In 1996, according to reporting and serologic data, the increase in pertussis incidence among (mostly unvaccinated) children less than 1 year of age was similar to the increase in hospital admissions. Among older (mostly vaccinated) persons, the increase in hospital admissions was relatively small. The increase in pertussis incidence was higher among vaccinated than among unvaccinated persons of all ages. This resulted in lower estimates of vaccine effectiveness. The proportion of pertussis infections resulting in recognizable symptoms may have increased among vaccinated persons because of a mismatch of the vaccine strain and circulating Bordetella pertussis strains. The small immunogenicity profile of the Dutch vaccine may have resulted in greater vulnerability to antigenic changes in B. pertussis.
Sujet(s)
Épidémies de maladies , Vaccin anticoquelucheux , Surveillance de la population , Vaccination , Coqueluche/épidémiologie , Adolescent , Adulte , Répartition par âge , Anticorps antibactériens/sang , Bordetella pertussis/immunologie , Enfant , Enfant d'âge préscolaire , Notification des maladies , Hospitalisation/statistiques et données numériques , Humains , Incidence , Nourrisson , Nouveau-né , Pays-Bas/épidémiologie , Vaccin anticoquelucheux/immunologie , Saisons , Coqueluche/diagnosticRÉSUMÉ
In 1996 an unexpected rise in the incidence of whooping cough occurred in the Netherlands, and antigenic divergence between vaccine strains and clinical isolates has been suggested as a cause for this phenomenon. To investigate this assumption, the binding of murine antibodies against the whole-cell pertussis vaccine or filamentous haemagglutinin, an important protective antigen, to a limited number of Bordetella pertussis strains isolated during different time-periods (1991-92, 1994 and 1996) was assessed. The results showed that all strains were recognized equally well by these antisera, indicating that filamentous haemagglutinin was unchanged during the time-periods examined. Although over the years changes have occurred in at least two surface proteins of B. pertussis, these changes are too subtle to be recognized by the antibodies raised in mice. Further research is required to assess whether antigenic variation of B. pertussis has an effect on protective immunity.